Department of Nuclear Medicine, Pitié Salpêtrière Hospital, Paris cedex, France.
Ann Endocrinol (Paris). 2011 Jun;72(3):173-97. doi: 10.1016/j.ando.2011.04.001. Epub 2011 Jun 8.
Good practice guide for cervical ultrasound scan and echo-guided techniques in treating differentiated thyroid cancer of vesicular origin. American, European and French Recommendations for the treatment of differentiated vesicular thyroid cancer were recently published. Cervical ultrasound scanning is now considered a key examination in the follow-up of these cancers. This examination is noninvasive, easy to perform and to obtain, is not costly, but remains operator-dependent. To date, there are no recommendations published that assemble all the technical aspects, results, indications and the limits of this examination in the initial medical report and the follow-up of these cancers. In order to standardise the procedure and validate the quality of the examination, a workgroup made up of a panel of experts particularly involved in carrying out ultrasound scans was set up. The aim was to draw up a good practice guide for performing cervical ultrasound scans and echo-guided techniques in treating patients with differentiated thyroid cancer of vesicular origin. The main objectives are to: (a) standardise the procedure and reports, (b) define the criteria for establishing whether lesions identified during a cervical ultrasound scan are malignant or benign, (c) standardise the indications for carrying out cytological tests and an in situ assay of markers, (d) help doctors to select the patients who ought to receive a cervical ultrasound scan and or cytological tests, (e) discuss how frequently the examinations should be carried out depending on the risk of recurrence.
《超声引导下甲状腺滤泡细胞癌诊治的规范化操作指南》。近年来,欧美及法国相继发布了分化型甲状腺滤泡细胞癌的诊治指南。目前,超声检查已成为此类肿瘤随访的重要检查手段,该检查具有无创、操作简便、获取结果迅速、价格低廉等优点,但仍具有很强的操作者依赖性。目前,在初始报告和随访过程中,尚未有将该检查的所有技术要点、结果、适应证及局限性进行汇总的推荐意见。为了规范操作流程,保证检查质量,我们成立了一个由从事甲状腺超声检查的专家组成的工作组,旨在制定《超声引导下甲状腺滤泡细胞癌诊治的规范化操作指南》。该指南的主要目的是:(1)规范操作流程和报告内容;(2)明确颈部超声检查中发现的病灶良恶性判断标准;(3)明确细胞学及原位免疫组化检测的适应证;(4)帮助临床医生选择需要行颈部超声检查及细胞学检查的患者;(5)讨论基于肿瘤复发风险的颈部超声检查及细胞学检查的频次。